HRMY Harmony Biosciences Holdings

$37.86

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.

Website: https://www.harmonybiosciences.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1802665
Address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, US
Valuation
Market Cap
$1.63B
P/E Ratio
11.34
PEG Ratio
nan
Price to Book
2.48
Performance
EPS
$2.51
Dividend Yield
—
Profit Margin
20.40%
ROE
25.80%
Technicals
50D MA
$33.47
200D MA
$34.76
52W High
$41.61
52W Low
$26.47
Fundamentals
Shares Outstanding
57M
Target Price
$51.89
Beta
0.80

HRMY EPS Estimates vs Actual

● Estimated
● Actual

HRMY News & Sentiment

Aug 08, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Aug 05, 2025 • Zacks Commentary NEUTRAL
Harmony Biosciences Holdings, Inc. ( HRMY ) Misses Q2 Earnings and Revenue Estimates
Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -12.82% and -1.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 30, 2025 • Zacks Commentary NEUTRAL
Analysts Estimate Stoke Therapeutics, Inc. ( STOK ) to Report a Decline in Earnings: What to Look Out for
Stoke Therapeutics (STOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jul 29, 2025 • Zacks Commentary NEUTRAL
Harmony Biosciences Holdings, Inc. ( HRMY ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Harmony Biosciences (HRMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jul 25, 2025 • Zacks Commentary SOMEWHAT-BULLISH
REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
Strong Dupixent profits and rising Eylea HD demand may help Regeneron offset pressure in its Q2 earnings report.
Jul 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View
THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier view of $11.99-$13.12.
Sentiment Snapshot

Average Sentiment Score:

0.334
50 articles with scored sentiment

Overall Sentiment:

Bullish

HRMY Reported Earnings

Apr 28, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 20, 2025
Dec 31, 2024 (Pre market)
0.26 Surprise
  • Reported EPS: $1.08
  • Estimate: $0.82
  • Whisper: —
  • Surprise %: 32.2%
Oct 29, 2024
Sep 30, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $0.79
  • Estimate: $0.67
  • Whisper: —
  • Surprise %: 17.9%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.26 Surprise
  • Reported EPS: $0.20
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: 433.3%
Apr 30, 2024
Mar 31, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $0.67
  • Estimate: $0.60
  • Whisper: —
  • Surprise %: 11.7%
Feb 22, 2024
Dec 31, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.45
  • Estimate: $0.48
  • Whisper: —
  • Surprise %: -6.2%
Oct 31, 2023
Sep 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $0.75
  • Estimate: $0.65
  • Whisper: —
  • Surprise %: 15.4%
Aug 01, 2023
Jun 30, 2023 (Pre market)
-0.07 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.63
  • Whisper: —
  • Surprise %: -11.1%
May 02, 2023
Mar 31, 2023 (Pre market)
0.19 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.47
  • Whisper: —
  • Surprise %: 40.4%

Financials